 |
|
Vulvovaginal Lichen PlanusA Disease in Need of a Unified Approach
Sallie M. Neill, FRCP;
Fiona M. Lewis, MD, FRCP
Arch Dermatol. 2008;144(11):1502-1503.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Lichen planus (LP), despite being described over a century ago, remains a disease of unknown etiology without one single effective treatment, as highlighted in the article by Cooper et al in this issue of the Archives.1 One of the most challenging conditions seen in clinics dedicated to vulval disease is the vulvovaginal-gingival syndrome described by Pelisse et al2 in 1982 that affects the vulval skin and vaginal mucosa. Mucosal LP runs a chronic and debilitating course with painful erosions on the oral and genital mucous membranes, which can have a major impact on the patient's quality of life.3 In addition to the clinically significant symptoms related to the inflammatory process, there are the sequelae of vulval scarring and vaginal stenosis that have an impact on sexual function, as well as a small but definite risk of malignant change. Therefore, effective . . . [Full Text of this Article]
AUTHOR INFORMATION
RELATED ARTICLES
The Association of Lichen Sclerosus and Erosive Lichen Planus of the Vulva With Autoimmune Disease: A Case-Control Study
Susan M. Cooper, Iaisha Ali, Maha Baldo, and Fenella Wojnarowska
Arch Dermatol. 2008;144(11):1432-1435.
ABSTRACT
| FULL TEXT
Vulvovaginal Lichen Planus Treatment: A Survey of Current Practices
Susan M. Cooper, Hope K. Haefner, Shafika Abrahams-Gessel, and Lynette J. Margesson
Arch Dermatol. 2008;144(11):1520-1521.
EXTRACT
| FULL TEXT
|
